Fig. 8From: Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysisRNF149 and its association with multidrug resistance. A Spearman’s analysis of the correlation between risk scores and drug sensitivity. Each row corresponds to a drug. The length of each row signifies the degree of correlation, suggesting an association between the risk score and either drug resistance or sensitivity; B A count of published articles concerning 82 chemotherapy drugs used for acute myeloid leukemia (AML), sourced from PubMed; C IC50 values for nine chemotherapy drugs in AML patients expressing high levels of RNF149Back to article page